BDX vs LMAT
As of Sep 20, 2026, Becton Dickinson (BDX) scores 6.7/10 and Lemaitre Vascular (LMAT) 3.5/10 on AlphaStocks' five-model composite, so BDX scores higher. BDX trades 21% above its model fair value; LMAT trades 17% above its model fair value.
BDX
BECTON DICKINSON & CO
6.7
Consider Buy
$180.78
LMAT
LEMAITRE VASCULAR INC
3.5
Weak
$78.88
BDX vs LMAT: Which is the Better Investment?
BECTON DICKINSON & CO (BDX) scores 6.7/10 while LEMAITRE VASCULAR INC (LMAT) scores 3.5/10 on AlphaStocks' composite model. BECTON DICKINSON & CO has the higher composite rating of Consider Buy. On a P/E basis, BECTON DICKINSON & CO trades at 31.1x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | BDX | LMAT |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.7/10▲ | 3.5/10 |
| Rating | Consider Buy▲ | Weak |
| Price | $180.78 | $78.88 |
| P/E Ratio | 31.1▲ | 31.3 |
| ROE | 6.6% | 14.9%▲ |
| Market Cap | $51B | $2B |
| Fair Value | $149.03 | $67.42 |
| Dividend Yield | 2.7%▲ | 0.8% |
| Sector Rank | #20 of 168▲ | #148 of 168 |
| Model Verdicts | ||
| Piotroski | Attractive | Attractive |
| Buffett | Strong▲ | Attractive |
| Graham | Caution | Neutral▲ |
| Lynch | Caution | Neutral▲ |
| Greenblatt | Strong▲ | Caution |
Related comparisons
BDX vs LMAT: Which Stock Scores Higher?
BECTON DICKINSON & CO (BDX) and LEMAITRE VASCULAR INC (LMAT) are both in the Health Care sector. BDX currently leads with a composite score of 6.7/10 (Consider Buy) compared to LMAT's 3.5/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer